EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review

Wirkung oraler Antidiabetika auf die Intima-Media-Dicke der Karotis bei Patient:innen mit kardiovaskulärer Erkrankung und/oder Diabetes – systematische Übersichtsarbeit

Ali Shabu, Syed Mohammad Naqvi iD, Farshad Hesari, Syed Yaseen Naqvi, Wael Tawfick

Endocrinology, Diabetes & Metabolism · 2025-11 · 8 (6)

DOI: 10.1002/edm2.70140 ↗

Auf einen Blick

Die systematische Übersichtsarbeit fand 13 RCTs mit 3849 Teilnehmenden. Pioglitazon, Repaglinid und Alogliptin zeigten teils eine Verlangsamung der CIMT-Progression.

Fragestellung

Welchen Einfluss haben orale hypoglykämische Wirkstoffe auf die Karotis-Intima-Media-Dicke (CIMT) bei Patient:innen mit ASCVD und/oder Diabetes mellitus?

Methode

Systematische Suche in Cochrane, Embase, CINAHL, Scopus und PubMed nach RCTs; Auswertung der Wirksamkeit und unerwünschten Wirkungen bei Erwachsenen mit Diabetes und/oder kardiovaskulärer Erkrankung.

Ergebnisse

13 ausgewählte Studien mit 3849 Teilnehmenden. Pioglitazon war in 2 von 3 Studien mit verlangsamter CIMT-Progression verbunden; Repaglinid reduzierte CIMT und Entzündung, Rosiglitazon ohne signifikanten Effekt. Metformin, Sitagliptin und Alogliptin zeigten gemischte Ergebnisse; Tofogliflozin und Ipragliflozin ohne signifikante CIMT-Reduktion.

Schlussfolgerung der Autor:innen

Die Autor:innen schlussfolgern, dass eine längere Anwendung von Pioglitazon, Repaglinid und Alogliptin die CIMT-Progression deutlich verlangsamen könnte. Weitere Forschung sei nötig.

Kernaussagen

  • 13 RCTs mit 3849 Teilnehmenden
  • Pioglitazon und Repaglinid zeigten teils günstigere CIMT-Ergebnisse
  • Für einige Wirkstoffe waren die Ergebnisse gemischt oder ohne signifikanten Effekt

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Endocrinology, Diabetes & Metabolism, published online on 2025-11-20. Written by Ali Shabu and 4 co-authors. Institution: National Institute for Prevention and Cardiovascular Health (NIPC), University of Galway, Galway, Ireland. Major MEDLINE topics: Carotid Intima-Media Thickness, Hypoglycemic Agents, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0).

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Atherosclerotic cardiovascular disease (ASCVD) is a global concern, with diabetes being a key risk factor. Preventive measures increasingly rely on surrogate markers, such as carotid artery intima‐media thickness (CIMT), a marker linked to ASCVD. Given the connection between dysglycaemia and ASCVD, the impact of oral hypoglycaemic agents (OHA) on CIMT is of interest. Despite the cardiovascular benefits of several OHAs, their effect on CIMT remains uncertain. This review aims to clarify the influence of OHAs on CIMT in patients with ASCVD and/or diabetes.

Objectives

This systematic review aims to assess the effect of OHAs on CIMT in patients with ASCVD and/or diabetes mellitus (Type 1 or Type 2). We aim to provide evidence on the role of OHAs in reducing cardiovascular events in these high‐risk patients. Methodology A systematic search of databases, including Cochrane, Embase, CINAHL, Scopus and PubMed, was conducted to identify relevant randomised controlled trials (RCTs). We analysed the efficacy and adverse effects of OHAs on CIMT in adults with diabetes and/or cardiovascular disease.

Results

The initial search identified 629 studies, with 13 selected, involving 3849 participants. Pioglitazone showed effectiveness in slowing CIMT progression in two out of three studies. Repaglinide was effective in reducing CIMT and inflammation, while Rosiglitazone showed no significant effect. Metformin, Sitagliptin and Alogliptin studies yielded mixed results, with some showing reduced CIMT progression but increased gastrointestinal and hypoglycaemia risks. SGLT‐2 inhibitors Tofogliflozin and Ipragliflozin showed no significant CIMT reduction.

Conclusion

The study suggests that prolonged use of Pioglitazone, Repaglinide and Alogliptin may significantly slow CIMT progression, improving cardiovascular risk management in patients with diabetes and/or cardiovascular disease. Further research is needed to understand the benefits and optimise oral hypoglycaemic treatment strategies for these patients.

Subjects

MeSH terms (MEDLINE)

Carotid Intima-Media ThicknessHypoglycemic AgentsCardiovascular DiseasesDiabetes Mellitus, Type 2HumansAdministration, Oral

Author keywords

DPP‐4 inhibitorsSGLT‐2 inhibitorscardiovascular diseasecarotid artery intima‐media thicknessdiabetes mellitusmetforminoral hypoglycaemic agentssulfonylureasthiazolidinediones

Substances

Hypoglycemic Agents

Authors and institutions

  • National Institute for Prevention and Cardiovascular Health (NIPC), University of Galway, Galway, Ireland.
  • Faculty of Education and Health Sciences, University of Limerick, Limerick, Ireland.
  • Centre for Languages and Literature, Lund University, Lund, Sweden.

ORCID profiles: Syed Mohammad Naqvi

Cite

APA

Shabu, A., Naqvi, S. M., Hesari, F., Naqvi, S. Y., & Tawfick, W. (2025). Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review. Endocrinology, Diabetes & Metabolism, 8(6). https://doi.org/10.1002/edm2.70140

Vancouver

Shabu A, Naqvi SM, Hesari F, Naqvi SY, Tawfick W. Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review. Endocrinology, Diabetes & Metabolism. 2025;8(6). doi:10.1002/edm2.70140

BibTeX
@article{Shabu2025,
  author = {Shabu, Ali and Naqvi, Syed Mohammad and Hesari, Farshad and Naqvi, Syed Yaseen and Tawfick, Wael},
  title = {Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima‐Media Thickness in Patients With Cardiovascular Disease and/or Diabetes—A Systematic Review},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2025},
  volume = {8},
  number = {6},
  doi = {10.1002/edm2.70140}
}
Start for free →